Genetic depletion and pharmacological inhibition of TRPML1 promote ferroptosis in breast CSCs, reduce their stemness, and enhances the sensitivity of breast cancer cells to conventional chemotherapy drug doxorubicin (DOX). The gene discussed is MCOLN1; the disease is breast carcinoma.